Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility

The value of in silico methods in drug development and evaluation has been demonstrated repeatedly and convincingly. While their benefits are now unanimously recognized, international standards for their evaluation, accepted by all stakeholders involved, are still to be established. In this white pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Musuamba, Flora T., Skottheim Rusten, Ine, Lesage, Raphaëlle, Russo, Giulia, Bursi, Roberta, Emili, Luca, Wangorsch, Gaby, Manolis, Efthymios, Karlsson, Kristin E., Kulesza, Alexander, Courcelles, Eulalie, Boissel, Jean‐Pierre, Rousseau, Cécile F., Voisin, Emmanuelle M., Alessandrello, Rossana, Curado, Nuno, Dall’ara, Enrico, Rodriguez, Blanca, Pappalardo, Francesco, Geris, Liesbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
White Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376137/
https://www.ncbi.nlm.nih.gov/pubmed/34102034
http://dx.doi.org/10.1002/psp4.12669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376137/
https://www.ncbi.nlm.nih.gov/pubmed/34102034
http://dx.doi.org/10.1002/psp4.12669

Ejemplares similares